Association between low dose acetylsalicylic acid (ASA) and proton pump inhibitors and risk of acute myocardial infarction or coronary heart disease death

Study identifier:D961FN00007

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Association between low dose acetylsalicylic acid (ASA) and proton pump inhibitors and risk of acute myocardial infarction or coronary heart disease death - Nested case control analyses in a cohort of patients with acute serious coronary heart disease

Medical condition

Nonfatal Myocardial infarction

Phase

-

Healthy volunteers

No

Study drug

-

Sex

All

Actual enrollment

42542

Study type

Observational

Age

50 Years - 84 Years

Date

Study Start Date: 01 Jul 2011
Primary Completion Date: 01 Dec 2011
Study Completion Date: 01 Dec 2011

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Jan 2014 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria